REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 39 filers reported holding REPARE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,044,552 | +5.5% | 1,079,847 | -7.6% | 0.00% | 0.0% |
| Q2 2023 | $12,361,746 | -31.8% | 1,168,407 | -36.6% | 0.00% | 0.0% |
| Q1 2023 | $18,124,158 | +40.6% | 1,841,886 | +110.2% | 0.00% | 0.0% |
| Q4 2022 | $12,888,578 | +499.5% | 876,178 | +394.4% | 0.00% | – |
| Q3 2022 | $2,150,000 | -88.8% | 177,230 | -87.1% | 0.00% | -100.0% |
| Q2 2022 | $19,242,000 | -54.0% | 1,375,388 | -53.2% | 0.00% | -33.3% |
| Q1 2022 | $41,863,000 | -34.3% | 2,939,823 | -2.7% | 0.00% | -40.0% |
| Q4 2021 | $63,720,000 | -12.8% | 3,021,313 | +8.5% | 0.01% | -16.7% |
| Q3 2021 | $73,046,000 | -15.6% | 2,783,776 | +0.3% | 0.01% | -14.3% |
| Q2 2021 | $86,526,000 | +1.9% | 2,775,053 | +0.3% | 0.01% | 0.0% |
| Q1 2021 | $84,944,000 | -10.2% | 2,767,833 | +0.4% | 0.01% | -12.5% |
| Q4 2020 | $94,577,000 | +11.5% | 2,757,375 | +0.0% | 0.01% | -11.1% |
| Q3 2020 | $84,817,000 | +8.2% | 2,756,509 | +9.1% | 0.01% | 0.0% |
| Q2 2020 | $78,401,000 | – | 2,527,453 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,560,703 | $78,588,000 | 15.73% |
| MPM ASSET MANAGEMENT LLC | 2,603,089 | $79,889,000 | 15.43% |
| MPM BioImpact LLC | 2,069,749 | $63,521,000 | 7.98% |
| BVF INC/IL | 3,722,398 | $114,240,000 | 4.28% |
| StepStone Group LP | 8,721 | $268,000 | 4.12% |
| Logos Global Management LP | 900,000 | $27,621,000 | 2.70% |
| Redmile Group, LLC | 2,665,496 | $81,804,000 | 1.15% |
| Orbimed Advisors | 3,426,325 | $105,154,000 | 0.98% |
| Soleus Capital Management, L.P. | 133,324 | $4,092,000 | 0.74% |
| SPHERA FUNDS MANAGEMENT LTD. | 248,100 | $7,614,000 | 0.58% |